G L King

3.1k citations

14 papers · 2.1k indexed · 1 hit paper · h-index 12

Impact in

Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
Ophthalmology top 1%
- Retinal Diseases and Treatments

Papers in

Ophthalmology 5
- Retinal Diseases and Treatments 5
- Glaucoma and retinal disorders 2
Endocrinology, Diabetes and Metabolism 4
- Growth Hormone and Insulin-like Growth Factors 2

Co-authors: Daisuke Koya Ruth M. Kramer Pu Xia Sven–Erik Bursell Hitoshi Takagi Christopher J. Rhodes Matthias Meier Hidehiro Ishii
Journals: Diabetes (3 papers)Journal of Clinical Investigation (2 papers)Diabetes Research and Clinical Practice (2 papers)Retina (1 paper)New England Journal of Medicine (1 paper)
Partner nations: United States Switzerland Australia

In The Last Decade

G L King

14 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Protein kinase C activation and the development of diabetic complications. 1998 · 1.1k citations

Peers

Countries citing papers authored by G L King

Since Specialization

Citations

This map shows the geographic impact of G L King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G L King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G L King more than expected).

Fields of papers citing papers by G L King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G L King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G L King. The network helps show where G L King may publish in the future.

Co-authors

The 25 scholars most cited alongside G L King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G L King Line = papers co-authored together G L King links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Pigment-Epithelium–Derived Factor — A Key Coordinator of Retinal Neuronal and Vascular Functions New England Journal of Medicine ·G L King, Kiyoshi Suzuma	2000	64
2	Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways Journal of Clinical Investigation ·Masahiko Igarashi, Hisao Wakasaki, Noriko Takahara, Hidehiro Ishii, Zhen Jiang, Teruaki Yamauchi, Koji Kuboki, Matthias Meier, Christopher J. Rhodes, G L King	1999	343
3	d-α-Tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity Diabetes Research and Clinical Practice ·In Kyu Lee, Daisuke Koya, Hidehiro Ishi, Hideo Kanoh, G L King	1999	48
4	Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? Diabetes Research and Clinical Practice ·Sven–Erik Bursell, G L King	1999	64
5	Protein kinase C activation and the development of diabetic complications. Diabetes ·Daisuke Koya, G L King Hit paper breakdown →	1998	1050
6	Vascular Endothelial Growth Factor-Induced Retinal Permeability is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform-Selective Inhibitor. Retina ·L P Aiello, S.E. Bursell, Allen C. Clermont, Elia J. Duh, Hiroko Ishii, Chikako Takagi, Fumihiko Mori, Thomas A. Ciulla, Kirk Ways, M.R. Jirousek, L E. H Smith, G L King	1998	6
7	Identification of a VEGF receptor (KDR/FLK) promoter element which binds an endothelial cell-specific protein conferring endothelial selective expression Elia J. Duh, G L King, Lloyd Paul Aiello	1997	3
8	The Role of Hyperglycaemia and Hyperinsulinaemia in Causing Vascular Dysfunction in Diabetes Annals of Medicine ·G L King	1996	62
9	Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. PubMed ·Hitoshi Takagi, G L King, Napoleone Ferrara, Lloyd Paul Aiello	1996	101
10	Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. PubMed ·Chikako Takagi, G L King, Hitoshi Takagi, You Wei Lin, Allen C. Clermont, Sven–Erik Bursell	1996	56
11	Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. Journal of Clinical Investigation ·Pu Xia, Ruth M. Kramer, G L King	1995	142
12	Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes Diabetes ·Guadalupe de la Rubia, F. Javier Oliver, Toyoshi Inoguchi, G L King	1992	42
13	Insulin, Insulin-Like Growth Factor I and Platelet-Derived Growth Factor Interact Additively in the Induction of the Protooncogenec-mycand Cellular Proliferation in Cultured Bovine Aortic Smooth Muscle Cells Molecular Endocrinology ·Nirmal K. Banskota, Rebecca Taub, Karen Zellner, G L King	1989	110
14	Comparative Studies on Insulin-Like Growth Factor II and Insulin Processing by Vascular Endothelial Cells Diabetes ·HARUMI L. HACHIYA, J L Carpentier, G L King	1986	20

About G L King

G L King is a scholar working on Ophthalmology, Endocrinology, Diabetes and Metabolism, Physiology, Biochemistry and Clinical Biochemistry, having authored 14 papers that have together received 2.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (5 papers), Retinal Development and Disorders (3 papers), Glaucoma and retinal disorders (2 papers), Retinopathy of Prematurity Studies (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Clinical Biochemistry (477 citations), Ophthalmology (384 citations), Endocrinology, Diabetes and Metabolism (457 citations), Nephrology (162 citations) and Physiology (500 citations). G L King has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Daisuke Koya, Ruth M. Kramer, Pu Xia, Sven–Erik Bursell, Hitoshi Takagi, Christopher J. Rhodes, Matthias Meier, Hidehiro Ishii, Noriko Takahara and Masahiko Igarashi. Their work appears in journals such as Diabetes, Journal of Clinical Investigation, Diabetes Research and Clinical Practice, Retina and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact